Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -20.77% | $213.46M | 0.5% |
UUP | -20.58% | $327.80M | 0.77% |
EQLS | -17.61% | $4.77M | 1% |
UGA | -16.71% | $88.11M | 0.97% |
USL | -16.55% | $46.60M | 0.85% |
DBE | -15.96% | $54.58M | 0.77% |
DBO | -15.79% | $197.54M | 0.77% |
OILK | -15.12% | $66.42M | 0.69% |
BNO | -14.03% | $95.40M | 1% |
USO | -13.96% | $1.02B | 0.6% |
MAGS | -12.33% | $1.72B | 0.29% |
COMT | -11.90% | $674.22M | 0.48% |
TESL | -11.75% | $16.08M | 1.2% |
PDBC | -11.69% | $4.82B | 0.59% |
BLCN | -11.57% | $43.07M | 0.68% |
TPMN | -11.40% | $33.51M | 0.65% |
GSG | -11.37% | $1.04B | 0.75% |
DBC | -10.91% | $1.32B | 0.87% |
CLSE | -10.79% | $167.58M | 1.55% |
YMAG | -10.48% | $299.07M | 1.12% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 57.25% | $664.88M | 0.36% |
IXJ | 51.90% | $3.93B | 0.41% |
RSPH | 45.94% | $790.11M | 0.4% |
XLV | 45.69% | $38.07B | 0.09% |
IYH | 45.42% | $3.18B | 0.39% |
SCHY | 45.27% | $927.84M | 0.08% |
EFAV | 44.08% | $4.71B | 0.2% |
VHT | 43.91% | $16.42B | 0.09% |
EWL | 43.68% | $1.14B | 0.5% |
GCOW | 43.17% | $2.18B | 0.6% |
FHLC | 43.07% | $2.69B | 0.084% |
EWU | 42.53% | $3.25B | 0.5% |
KXI | 42.29% | $717.10M | 0.41% |
HDEF | 42.23% | $1.85B | 0.09% |
ACWV | 40.67% | $3.36B | 0.2% |
FXH | 39.89% | $960.13M | 0.62% |
IHE | 39.51% | $600.56M | 0.39% |
INDS | 39.31% | $144.65M | 0.55% |
BBH | 38.69% | $368.79M | 0.35% |
FLGB | 38.08% | $720.50M | 0.09% |
SeekingAlpha
Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and mRNA challenges. Learn more on MRNA stock here.
SeekingAlpha
Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock prospects.
SeekingAlpha
Alector, Inc. biopharma update: AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a Hold.
SeekingAlpha
GSK plc (NYSE:GSK) TD Cowen 45th Annual Health Care Conference March 3, 2024 9:50 AM ETCompany ParticipantsLuke Miels - Chief Commercial OfficerConference...
SeekingAlpha
The John Hancock Disciplined Value International Fund underperformed the benchmark. Click here to read the full commentary.
SeekingAlpha
Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK may work for income investors.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
COHR | -26.76% | $10.06B | +8.23% | 0.00% |
ALGT | -20.68% | $947.17M | -25.60% | 1.19% |
GRND | -19.24% | $3.73B | +74.98% | 0.00% |
GPCR | -15.99% | $991.63M | -57.68% | 0.00% |
DAKT | -15.33% | $607.70M | +21.56% | 0.00% |
GOOGL | -15.25% | $1.89T | -0.55% | 0.52% |
GEO | -15.00% | $4.17B | +104.84% | 0.00% |
GOOG | -14.82% | $1.90T | -0.17% | 0.51% |
SKYW | -14.80% | $3.55B | +27.10% | 0.00% |
CEG | -13.90% | $63.17B | +8.41% | 0.72% |
NVDA | -13.80% | $2.64T | +19.94% | 0.04% |
HUT | -13.70% | $1.21B | +7.39% | 0.00% |
DTM | -13.58% | $9.80B | +57.65% | 3.15% |
MYRG | -13.41% | $1.83B | -35.58% | 0.00% |
AAOI | -13.40% | $771.33M | +10.27% | 0.00% |
HUSA | -13.35% | $12.08M | -45.38% | 0.00% |
MTZ | -13.27% | $9.25B | +24.32% | 0.00% |
TSLA | -12.86% | $833.59B | +47.91% | 0.00% |
OWL | -12.71% | $12.54B | +7.92% | 3.57% |
GPOR | -12.49% | $3.29B | +15.21% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
AGZD | -<0.01% | $136.29M | 0.23% |
EPI | 0.05% | $3.06B | 0.85% |
IXN | -0.13% | $4.50B | 0.41% |
FTQI | -0.17% | $569.52M | 0.75% |
TFLO | 0.22% | $6.78B | 0.15% |
XLK | -0.24% | $64.20B | 0.09% |
ARKQ | -0.24% | $828.61M | 0.75% |
RSPG | -0.24% | $507.19M | 0.4% |
ICLO | -0.25% | $354.53M | 0.2% |
KCE | 0.27% | $481.16M | 0.35% |
PIN | 0.29% | $229.06M | 0.78% |
KRBN | 0.34% | $173.49M | 0.85% |
SPUS | -0.35% | $1.08B | 0.45% |
FTXN | -0.38% | $155.55M | 0.6% |
INDA | 0.39% | $8.88B | 0.62% |
FLTR | 0.41% | $2.42B | 0.14% |
QMOM | 0.45% | $289.88M | 0.29% |
BILZ | 0.52% | $709.48M | 0.14% |
MLPX | 0.53% | $2.77B | 0.45% |
NANC | 0.55% | $208.57M | 0.73% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NVS | 49.92% | $211.54B | +16.28% | 3.44% |
PFE | 48.14% | $143.71B | -8.59% | 6.70% |
SNY | 40.59% | $135.77B | +14.85% | 3.67% |
JNJ | 39.82% | $399.65B | +5.11% | 3.07% |
AZN | 39.22% | $227.94B | +9.29% | 2.10% |
AMGN | 38.38% | $167.37B | +10.07% | 2.94% |
SNN | 38.02% | $12.39B | +15.61% | 4.29% |
PSA | 36.05% | $52.50B | +4.46% | 3.99% |
OGN | 35.59% | $3.84B | -19.51% | 7.56% |
EHC | 35.06% | $10.20B | +21.69% | 0.48% |
HCA | 34.76% | $85.08B | +4.68% | 0.78% |
REGN | 34.73% | $69.34B | -34.57% | 0.00% |
ENSG | 34.72% | $7.43B | +4.46% | 0.19% |
GIS | 34.52% | $32.74B | -14.74% | 3.99% |
CUBE | 34.35% | $9.73B | -5.15% | 3.62% |
ZBH | 34.24% | $22.53B | -12.77% | 0.85% |
WPC | 33.95% | $13.81B | +12.56% | 5.53% |
PEP | 33.70% | $205.64B | -13.32% | 3.60% |
NTST | 33.60% | $1.29B | -13.15% | 5.23% |
TAK | 33.59% | $47.14B | +8.78% | 2.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
STR | -<0.01% | $1.55B | -20.04% | 7.03% |
MCRI | 0.01% | $1.44B | +4.90% | 1.54% |
EGHT | 0.01% | $263.39M | -25.37% | 0.00% |
DOCS | 0.01% | $10.89B | +119.73% | 0.00% |
QTWO | -0.02% | $4.86B | +58.19% | 0.00% |
STEL | 0.03% | $1.46B | +15.78% | 1.98% |
H | 0.03% | $11.78B | -22.52% | 0.49% |
SYM | 0.03% | $2.18B | -55.52% | 0.00% |
OKLO | -0.03% | $3.01B | +77.59% | 0.00% |
GDDY | 0.03% | $25.46B | +48.74% | 0.00% |
SAIA | 0.04% | $9.31B | -40.35% | 0.00% |
HLIT | -0.04% | $1.12B | -26.57% | 0.00% |
CRM | -0.06% | $257.89B | -11.22% | 0.45% |
OOMA | 0.06% | $353.43M | +54.00% | 0.00% |
MUFG | -0.06% | $158.11B | +36.57% | 1.25% |
WTI | 0.07% | $228.84M | -42.38% | 2.60% |
TEO | 0.07% | $1.28B | +32.34% | 0.00% |
GKOS | -0.08% | $5.57B | +5.71% | 0.00% |
NCMI | -0.09% | $555.92M | +9.77% | 0.00% |
WHF | 0.10% | - | - | 16.01% |
Current Value
$38.731 Year Return
Current Value
$38.731 Year Return